Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal glycine versus placebo crossover study in CRPS I with dystonia
NL-OMON27048Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of glycine in Complex Regional Pain Syndrome Type 1 (CRPS-1) (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Safety of intrathecal glycine. Started Nov 2005; status: active, not recruiting.
02
Drugs
glycine
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)
Beyond the preview
Go deeper on NL-OMON27048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27048.